Last updated: June 3, 2026
THERMAZENE suppliers: who manufactures and supplies silver sulfadiazine cream and generic alternatives
Executive summary: Thermazene is a brand name for silver sulfadiazine (topical antimicrobial) used for burns. Supply chain depends on the country-specific authorized product and whether the market is served by brand holders, generic manufacturers, or contract manufacturers. Without jurisdiction-specific label and regulatory listings, supplier identification cannot be completed accurately.
Who are the suppliers for THERMAZENE (silver sulfadiazine) by country?
Featured snippet answer: Suppliers for THERMAZENE are determined by the country’s registered product label (marketing authorization holder and manufacturer) and the listed manufacturing site on the local regulator’s database.
What entities are typically listed as “manufacturer” vs “marketing authorization holder”
- Marketing authorization holder (MAH): owns the product registration and often contracts manufacturing.
- Manufacturer (finished dosage): the listed site that fills and packs the cream.
- API supplier (upstream): silver sulfadiazine may be sourced from multiple API makers; the MAH may not disclose identity on-pack in all jurisdictions.
Why “THERMAZENE” supplier lists change by formulation
- Cream strength (commonly 1% silver sulfadiazine) and packaging can map to different manufacturing lines.
- Some markets carry thermazene via license/labeler arrangements where the same MAH uses different manufacturing sites across years.
Which companies manufacture silver sulfadiazine topical cream (THERMAZENE-equivalent)
Featured snippet answer: Silver sulfadiazine topical creams are made by multiple generic manufacturers globally; THERMAZENE-equivalents track the specific registered product’s MAH and manufacturing site in the target country.
Common supplier archetypes in silver sulfadiazine markets
- Local generic makers with FDA/EMA-equivalent registrations (where applicable).
- Global generic companies that sell through local distributors.
- Contract manufacturers producing for branded labelers under finished dosage agreements.
How to map “THERMAZENE” to the correct manufacturing entity
- Match the label claim and dosage form (cream) to the registered product record.
- Use the manufacturing site listed for the exact strength and pack.
What patents and exclusivity affect THERMAZENE sourcing?
Featured snippet answer: Silver sulfadiazine is a mature, off-patent active ingredient in most jurisdictions, so exclusivity is usually not a constraint for sourcing.
Typical practical impact on suppliers
- Multiple generic entrants reduce barriers to supply for creams using the same active ingredient and strength.
- Regulatory and quality systems (GMP inspection history, bioavailability for topical where required) become the main procurement differentiators rather than IP.
What is the Orange Book status of THERMAZENE (silver sulfadiazine) and what does that mean for suppliers?
Featured snippet answer: If a THERMAZENE-specific product is not listed, the relevant supplier landscape is still governed by whether an FDA-listed generic silver sulfadiazine cream exists and who holds the ANDA.
Supplier consequences of FDA listing
- ANDA holder becomes a key supplier identity.
- CMO production sites can differ from ANDA holder offices.
Which THERMAZENE suppliers are relevant for hospital burn units?
Featured snippet answer: Hospital procurement usually follows contracted distributors and wholesalers tied to the product’s national tender and availability, not the API supplier.
Procurement criteria hospitals use
- Supply continuity and lot release reliability
- Stability shelf life and storage conditions
- Evidence of GMP compliance for the manufacturer and the distribution chain
How do distributors and wholesalers impact “THERMAZENE” supplier identification?
Featured snippet answer: Wholesale distributors can be the apparent “supplier” even when the manufacturer is a different legal entity.
Key procurement mapping
- Wholesaler/distributor: logistics and billing interface for hospitals
- MAH/manufacturer: legal and manufacturing accountability for product quality
What generic entry risks exist for THERMAZENE and its silver sulfadiazine cream?
Featured snippet answer: Manufacturing and regulatory compliance risks drive generic entry outcomes more than patent barriers.
Where supply disruption typically occurs
- Batch failures in sterility/quality testing for topical products
- Manufacturing site inspections or remediations
- API sourcing tightness for silver sulfadiazine
Commercial supplier landscape: what determines who can sell THERMAZENE
Featured snippet answer: Who can sell THERMAZENE is determined by the registered product listing, packaging/strength variants, and the distribution authorization in each jurisdiction.
High-signal factors for buyer diligence
- Verified manufacturing site on the regulatory record
- Consistent batch availability across procurement cycles
- Recalls or quality alerts tied to the manufacturing location
Key Takeaways
- THERMAZENE is a silver sulfadiazine topical cream brand, and supplier identity is jurisdiction-specific.
- Accurate “who supplies THERMAZENE” requires matching the country’s registered product record to the MAH and manufacturing sites.
- For most markets, multiple generic silver sulfadiazine cream manufacturers exist, so procurement usually hinges on availability and GMP track record rather than patent exclusivity.
FAQs
- Is THERMAZENE the same as silver sulfadiazine 1% cream?
- Who is the marketing authorization holder for THERMAZENE in the US/EU/UK?
- Can hospitals substitute THERMAZENE with generic silver sulfadiazine cream?
- What manufacturing sites are used for THERMAZENE across different lots?
- Do silver sulfadiazine shortages come from API suppliers or finished dosage manufacturers?
References
- No sources cited because supplier names for THERMAZENE cannot be mapped to an authoritative manufacturing/MAH list from the provided prompt.
